NEUPHORIA THERAPEUTICS INC (NEUP) Forecast, Price Target & Analyst Ratings
NASDAQ:NEUP • US64136E1029
4.64 USD
+0.29 (+6.67%)
At close: Mar 4, 2026
4.64 USD
0 (0%)
Pre-Market: 3/5/2026, 5:22:57 AM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for NEUPHORIA THERAPEUTICS INC (NEUP).
Forecast Snapshot
Consensus Price Target
$9.96
+ 114.70% Upside
Next Earnings Forecast
Release DateMay 18, 2026
PeriodQ3 / 2026
EPS Estimate-$1.10
Revenue Estimate
ChartMill Buy Consensus
80.00%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$9.96
Upside
+ 114.70%
From current price of $4.64 to mean target of $9.96, Based on 9 analyst forecasts
Low
$2.32
Median
$7.14
High
$21.00
Price Target Revisions
1 Month
0.00%
3 Months
-32.33%
Price Target Summary
9 analysts have analysed NEUP and the average price target is 9.96 USD. This implies a price increase of 114.7% is expected in the next year compared to the current price of 4.64.
The average price target has been revised downward by 32.33% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
80.00%
NEUP was analyzed by 9 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about NEUP.
In the previous month the buy percentage consensus was at a similar level.
NEUP was analyzed by 9 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-12-05 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-09-11 | Maxim Group | Maintains | Buy -> Buy |
| 2025-08-26 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-04 | HC Wainwright & Co. | Maintains | Buy -> Buy |
Next Earnings Forecast Details
Next Earnings Details
Release DateMay 18, 2026
PeriodQ3 / 2026
EPS Estimate-$1.10
Revenue Estimate
Revenue Q2Q-100.00%
EPS Q2QN/A
Number of Analysts5
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
-4.50%
Next Earnings Summary
NEUP is expected to report earnings on 5/18/2026. The consensus EPS estimate for the next earnings is -1.1 USD and the consensus revenue estimate is 0 USD.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | -100.00% | 15.649M | -100.00% | 62.586M | 165.11M 163.81% | 278.77M 68.84% | 367.72M 31.91% | |||||
| EBITDA YoY % growth | -21.32M | -17.229M 19.19% | -466.1K 97.29% | -16.524M -3,445.16% | -18.768M -13.58% | -21.93M -16.85% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -21.983M -36.13% | -17.892M 18.61% | -1.129M 93.69% | -16.621M -1,372.15% | -20.083M -20.83% | -30.928M -54.00% | -55.989M -81.03% | -23.819M 57.46% | 47.992M 301.48% | 135.08M 181.46% | 206.04M 52.53% | |
| Operating Margin | N/A | N/A | -7.21% | N/A | N/A | N/A | N/A | -38.06% | 29.07% | 48.46% | 56.03% | |
| EPS YoY % growth | N/A -104,017.17% | N/A -6.33% | N/A 101.51% | -5.58 -1,551.32% | -4.43 20.55% | -3.49 21.26% | N/A | N/A | N/A | N/A | N/A |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -1.10 | -1.21 79.15% | -1.47 66.58% | -1.50 -95.39% | -1.25 -13.08% | -1.27 -5.21% |
| Revenue Q2Q % growth | -100.00% | 100.00% | ||||
| EBITDA Q2Q % growth | -3.57M -128.62% | -3.672M 29.00% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -4.421M -136.91% | -5.095M 12.68% | -4.876M 13.74% | -5.031M -78.10% | -5.339M -20.76% | -5.494M -7.83% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
-122.93%
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
-25.99%
Revenue Next 5 Year
42.50%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
-65.01%
EBIT Next 5 Year
N/A
NEUPHORIA THERAPEUTICS INC / NEUP Forecast FAQ
What is the price target for NEUP stock?
9 analysts have analysed NEUP and the average price target is 9.96 USD. This implies a price increase of 114.7% is expected in the next year compared to the current price of 4.64.
When does NEUPHORIA THERAPEUTICS INC (NEUP) report earnings?
NEUPHORIA THERAPEUTICS INC (NEUP) will report earnings on 2026-05-18.
Can you provide the consensus estimates for NEUPHORIA THERAPEUTICS INC next earnings?
The consensus EPS estimate for the next earnings of NEUPHORIA THERAPEUTICS INC (NEUP) is -1.1 USD and the consensus revenue estimate is 0 USD.
What is the expected long term growth rate for NEUP stock?
The expected long term growth rate for NEUPHORIA THERAPEUTICS INC (NEUP) is -25.99%.